Rx-360 is moving its main office to Philadelphia, Pennsylvania. This move will be effective March 1, 2019. The move is designed to help the organization increase its scope and interaction with their Membership as it continues to drive towards the mission of supply chain security and patient safety in the pharmaceutical and medical device arena.
Jim Fries, Rx-360 CEO, commented, “This move will allow us to reach our membership in a more personal and face to face way. Philadelphia is a perfect central hub for us and will allow us to continue our growth.”
Rx-360 recently announced significant milestone achievements from 2018, that included all-time production and member interaction in the areas of their industry-specific working groups, joint audit program, and audit license program.
Rx-360 Chairman, Tim Valko of Atara Biotherapeutics, expressed, “After the success Rx-360 had in 2018, this move will allow our team to engage more directly with our membership and continue our growth as a leader in the biotechnology, pharmaceutical, and medical device worlds.”
Rx-360 beginning March 1, 2019 will be located at 234 Market Street, Philadelphia, PA. Rx-360 is a member-based, non-profit international consortium, of volunteer industry leaders, dedicated to the security of the pharmaceutical and medical device supply chain and patient safety. For information on membership and other opportunities at Rx-360, please call 1-888-218-1164.